Cargando…
Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity
Alpha-L-fucosidase (AFU) has been reported to be a predictor of survival in patients with several cancers, but it is unclear whether AFU is associated with prognosis in patients with intrahepatic cholangiocarcinoma (iCCA). In this study, we used receiver operating characteristic (ROC) analysis to ge...
Autores principales: | Shuang, Zeyu, Mao, Yize, Lin, Guohe, Wang, Jun, Huang, Xin, Chen, Jianlin, Duan, Fangting, Li, Shengping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842738/ https://www.ncbi.nlm.nih.gov/pubmed/29682557 http://dx.doi.org/10.1155/2018/8182575 |
Ejemplares similares
-
Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma
por: Lin, Guohe, et al.
Publicado: (2016) -
PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation
por: Mao, Yize, et al.
Publicado: (2018) -
Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma
por: Zhang, Chenyue, et al.
Publicado: (2017) -
Prognostic and immunological role of alpha-L-fucosidase 2 (FUCA2) in hepatocellular carcinoma
por: Hu, Yuanhui, et al.
Publicado: (2023) -
Efficacy and Safety of Apatinib Treatment for Patients with Advanced Intrahepatic Cholangiocarcinoma
por: Lin, Guohe, et al.
Publicado: (2020)